Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Axtell

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Immunity|May 17, 2008
Type 1 interferons cool the inflamed brainRobert C Axtell, Lawrence Steinman
Nature Immunology|April 22, 2009
Gaining entry to an uninflamed brainRobert C Axtell, Lawrence Steinman
International Journal of Molecular Sciences|February 11, 2023
Dual Role of B Cells in Multiple SclerosisGaurav Kumar, Robert C Axtell
Immunological Reviews|June 26, 2012
Janus-like effects of type I interferon in autoimmune diseasesRobert C Axtell, Chander Raman
International Journal of Molecular Sciences|October 24, 2018
Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune EncephalomyelitisJames L Quinn, Robert C Axtell
Trends in Immunology|May 3, 2011
Interferon-β exacerbates Th17-mediated inflammatory diseaseRobert C Axtell, Chander Raman, Lawrence Steinman
Clinical Reviews in Allergy & Immunology|January 11, 2012
Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunityRobert C Axtell, Chander Raman, Lawrence Steinman
Journal of Neuroimmunology|November 21, 2017
Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetineRoopa Bhat, Sidharth Mahapatra, Robert C Axtell, et al.
Cells|August 27, 2021
Interferon-β Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory DiseaseAgnieshka Agasing, James L Quinn, Gaurav Kumar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous systemRobert C Axtell, Liang Xu, Scott R Barnum, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Immunity|May 17, 2008
Type 1 interferons cool the inflamed brainRobert C Axtell, Lawrence Steinman
Nature Immunology|April 22, 2009
Gaining entry to an uninflamed brainRobert C Axtell, Lawrence Steinman
International Journal of Molecular Sciences|February 11, 2023
Dual Role of B Cells in Multiple SclerosisGaurav Kumar, Robert C Axtell
Immunological Reviews|June 26, 2012
Janus-like effects of type I interferon in autoimmune diseasesRobert C Axtell, Chander Raman
International Journal of Molecular Sciences|October 24, 2018
Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune EncephalomyelitisJames L Quinn, Robert C Axtell
Trends in Immunology|May 3, 2011
Interferon-β exacerbates Th17-mediated inflammatory diseaseRobert C Axtell, Chander Raman, Lawrence Steinman
Clinical Reviews in Allergy & Immunology|January 11, 2012
Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunityRobert C Axtell, Chander Raman, Lawrence Steinman
Journal of Neuroimmunology|November 21, 2017
Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetineRoopa Bhat, Sidharth Mahapatra, Robert C Axtell, et al.
Cells|August 27, 2021
Interferon-β Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory DiseaseAgnieshka Agasing, James L Quinn, Gaurav Kumar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous systemRobert C Axtell, Liang Xu, Scott R Barnum, et al.
Pageof 6